University of Minnesota. Driven to Discover.
Baloxavir reduced flu symptoms by 1 day and reduced viral shedding.
Both AAP and the CDC, though, support using FluMist with the goal of optimizing vaccine coverage.
The new data mark a 4th straight year of "steep and sustained" increases.
ACIP suggests vaccination by the end of October—but the start date is less clear.
The oropharyngeal cancer rate increased 2.8% per year in men and 0.6% in women.
Just over 40% of emergency department visits involved a child 2 years old or younger.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.